LERITONE Magnésium
Natural health product licensed in Canada
- Other names
- Noctima
- Licence holder
- IRB Yves Ponroy Canada Inc.
- NPN or DIN-HM
- 80028831
- Status
- Active licence
- Licence date
- 29 December 2011
- Revision date
- Not provided
- Form
- Gélule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
silice, Gélatine, Caramel, Maltodextrine, cellulose, Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2 Gélule | Not specified |
Uses authorised in Canada
Aide l'organisme à métaboliser les glucides (hydrates de carbone). Aide l'organisme à métaboliser les protéines. Aide l'organisme à métaboliser les lipides. Aide au développement et au maintien des os. Aide au développement et au maintien des dents. Aide à la formation de tissus. Aide au bon fonctionnement des muscles. Antioxydant pour le maintien d'une bonne santé.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80028831
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.